Roel Bakker
Roel Bakker
modeller of infectious disease epidemics, London School of Hygiene and Tropical Medicine
Geverifieerd e-mailadres voor lshtm.ac.uk
Geciteerd door
Geciteerd door
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention …
EL Korenromp, RG White, KK Orroth, R Bakker, A Kamali, D Serwadda, ...
The Journal of infectious diseases 191 (Supplement_1), S168-S178, 2005
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
Aids 26, S19-S30, 2012
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS medicine 10 (10), e1001534, 2013
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan …
EE Freeman, KK Orroth, RG White, JR Glynn, R Bakker, MC Boily, ...
Sexually transmitted infections 83 (suppl 1), i17-i24, 2007
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
RG White, JR Glynn, KK Orroth, EE Freeman, R Bakker, HA Weiss, ...
Aids 22 (14), 1841-1850, 2008
Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study
RG White, KK Orroth, EL Korenromp, R Bakker, M Wambura, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (4), 1500-1513, 2004
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study
KK Orroth, EE Freeman, R Bakker, A Buvé, JR Glynn, MC Boily, RG White, ...
Sexually transmitted infections 83 (suppl 1), i5-i16, 2007
Ageing with HIV in south africa
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
Aids 25 (13), 1665-1667, 2011
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?
RG White, KK Orroth, JR Glynn, EE Freeman, R Bakker, JDF Habbema, ...
Journal of acquired immune deficiency syndromes (1999) 47 (3), 346, 2008
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment
LE Coffeng, WA Stolk, A Hoerauf, D Habbema, R Bakker, AD Hopkins, ...
PloS one 9 (12), e115886, 2014
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial
EL Korenromp, R Bakker, SJ Vlas, RH Gray, MJ Wawer, D Serwadda, ...
Aids 16 (16), 2209-2218, 2002
cAMP-mediated effects of ouabain and theophylline on paracellular ion selectivity
R Bakker, JA Groot
American Journal of Physiology-Gastrointestinal and Liver Physiology 246 (2 …, 1984
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
EE Freeman, RG White, R Bakker, KK Orroth, HA Weiss, A Buvé, ...
Vaccine 27 (6), 940-946, 2009
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually …
KK Orroth, RG White, EL Korenromp, R Bakker, J Changalucha, ...
Sexually transmitted diseases, 536-544, 2006
Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework
LE Coffeng, R Bakker, A Montresor, SJ de Vlas
Parasites & vectors 8 (1), 1-16, 2015
HIV spread and partnership reduction for different patterns of sexual behaviour‐a study with the microsimulation model STDSIM
EL Korenromp, C Van Vliet, R Bakker, SJ de Vlas, JDF Habbema
Mathematical Population Studies 8 (2), 135-173, 2000
The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases
WK Redekop, EJ Lenk, M Luyendijk, C Fitzpatrick, L Niessen, WA Stolk, ...
PLoS neglected tropical diseases 11 (1), e0005289, 2017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20